Well being tech startup Colour raises $100M at a $4.6B valuation – TechCrunch

Well being tech startup Colour has raised $100 million in Collection E funding, bringing the corporate’s valuation to $4.6 billion. This spherical means Colour has now raised a complete of $378 million, with this newest spherical particularly meant to assist the corporate supply new packages that ship the final mile of care throughout healthcare companies.

The spherical was led by Kindred Ventures and by funds managed by T. Rowe Worth, together with participation from current traders together with Normal Catalyst, Viking World Buyers, and Emerson Collective. In January, Colour raised $167 million in Collection D funding, at a valuation of $1.5 billion. This newest spherical triples that measure of the corporate’s price.

Colour’s software program and infrastructure present instruments for preventative well being and infectious illness administration by making healthcare packages extra accessible. Up to now, Colour has partnered with virtually 1,000 organizations, together with public well being departments, employers, and universities to assist folks get sooner entry to healthcare companies. Its companions embody Salesforce, the Nationwide Institutes of Well being, the State of California, Thermo Fisher Scientific, and extra. The corporate at present facilitates over 6,500 COVID-19 testing websites at workplaces and colleges, and it additionally runs 500 vaccination websites throughout the nation.

“What we’ve constructed will function a crucial piece of public well being infrastructure to ship entry to healthcare companies to those that want them most,” mentioned Colour CEO Othman Laraki. “We’ve got discovered that there’s an exponential uptick in folks’s means to make use of these companies as they turn out to be easier and extra handy. Public well being ought to occur the place public life occurs.”

Finally, Colour’s method is to rethink healthcare supply with a view to make it accessible straight in folks’s lives with low transaction prices in a approach that’s scalable and doesn’t require loads of scientific resourcing.

With this newest spherical of funding, Colour goals to speed up the enlargement of accessible public well being infrastructure by serving to folks get entry to screening, diagnostics, and preliminary therapies for his or her well being wants. Colour’s choices will now embody vaccination and preventative well being companies for colleges and employers. It additionally plans to supply infectious illness administration packages sooner or later.

“Colour has constructed a robust, sustainable, and worthwhile enterprise that may scale alongside the myriad of well being challenges the U.S. faces,” mentioned Colour CFO Mike Herring. “The response from our companions has been extremely constructive, and our exceptional group has delivered at scale with each tempo and high quality of execution.”

Laraki co-founded Colour in 2013 based mostly on his personal expertise. The corporate tells TechCrunch his grandmother handed away from breast most cancers and that his mom is a breast most cancers survivor. He himself is a provider of a BRCA2 mutation, which might improve a person’s threat for most cancers. Discovering out this distinctive threat was difficult for him and he believed that the whole expertise felt like one thing that would have turn out to be a a lot easier healthcare transaction. Laraki’s expertise was the catalyst to constructing Colour, which now goals to make healthcare packages extra accessible and cost-effective.

The corporate says its mixture of current choices and new companies expands its efforts to construct public well being know-how and infrastructure for governments, employers, and different establishments that care for big populations.